NeuroDx is a clinical stage medical device company developing non-invasive diagnostic devices for the neurosurgery market. The firm is refining an FDA cleared device, ShuntCheck - a non-invasive, thermal dilution test for shunt function in hydrocephalus (âwater-on-the-brainâ) patients. CSF shunt failure is a life threatening medical condition but is diagnosed via CT scans of the brain (issue with radiation build up, especially in children) or radionuclide testing (invasive, risk of infection). ShuntCheck represents a safer and less expensive method for monitoring shunt function and identifying shunt malfunction. In response to yet2.com posting, the firm was identiifed as offering high interest solution to a NASA problem of there not being a proven method to quantify intracranial pressure non-invasivelywas. NeuroDx use of the carotid artery pulse pressure waveform that contains signals that are informative of the compliance in the cerebral vessels and thus, I
